CAMG
AQST icon

CWA Asset Management Group’s Aquestive Therapeutics AQST Stock Holding History

CWA Asset Management Group’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,811
Closed -$72K – 272
2021
Q1 		$72K Buy
13,811
+2,527
+22% +$13.4K 0.01% 269
2020
Q4 		$60K Buy
+11,284
New +$67.6K 0.01% 259
2020
Q3 		– Sell
-10,750
Closed -$52K – 227
2020
Q2 		$52K Buy
+10,750
New +$49.5K 0.01% 213

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LI
Latash Investments Anchorage, Alaska $129M AUM 14.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

CWA Asset Management Group's AQST Position: Q2 2021 in Review

CWA Asset Management Group sold out of Aquestive Therapeutics (AQST) in Q2 2021, closing a stake of 13,811 shares — an estimated $72K sold.

CWA Asset Management Group first reported a position in AQST in Q2 2020 and held it in 3 quarters. The position peaked at $72K in Q1 2021. 60 funds tracked by Wall St. Rank hold AQST as of Q2 2021.

  • CWA Asset Management Group reported no remaining Aquestive Therapeutics position as of Q2 2021 after selling out during the quarter.
  • CWA Asset Management Group sold 13,811 Aquestive Therapeutics shares in Q2 2021, an estimated $72K.
  • CWA Asset Management Group first reported a position in Aquestive Therapeutics in Q2 2020 and held it in 3 quarters.
  • CWA Asset Management Group's Aquestive Therapeutics position peaked at $72K in Q1 2021.
  • 60 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2021.

Based on CWA Asset Management Group's 13F filing for Q2 2021, filed 3 Aug 2021.